{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T10:08:52Z","timestamp":1789034932784,"version":"build-2803163510"},"reference-count":160,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2025-16068581"],"award-info":[{"award-number":["RS-2025-16068581"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"award":["RS-2025-16068581"],"award-info":[{"award-number":["RS-2025-16068581"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Programmed cell death is essential for maintaining cellular homeostasis, and its evasion is a defining hallmark of cancer. The threshold for apoptosis is largely determined by the stability of pro- and anti-apoptotic proteins, which is tightly regulated by the ubiquitin\u2013proteasome system (UPS). In this system, E1, E2, and E3 enzymes sequentially attach ubiquitin chains that mark substrates for degradation by the 26S proteasome, whereas deubiquitinating enzymes (DUBs) reverse these modifications to stabilize specific substrates. The opposing actions of E3 ubiquitin ligases and DUBs therefore form a dynamic network that fine-tunes the abundance of key apoptotic regulators and ultimately determines cell survival or death. In this review, we summarize how DUBs control the stability of central components of both the intrinsic and extrinsic apoptotic pathways, including the p53 pathway, BCL-2 family proteins such as MCL-1, and anti-apoptotic regulators including cellular FLICE-like inhibitory protein (c-FLIP) and inhibitor of apoptosis proteins (IAPs). We also discuss how linkage-specific ubiquitin editing at death receptor complexes influences the balance between survival and apoptosis. Finally, we discuss how dysregulation of DUB-mediated protein stability promotes apoptotic evasion in cancer and highlight the therapeutic potential of DUB-targeted strategies, including catalytic inhibitors and stabilization approaches such as deubiquitinase-targeting chimeras (DUBTACs).<\/jats:p>","DOI":"10.3390\/ijms27188049","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:13:03Z","timestamp":1789031583000},"page":"8049","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Balancing Ubiquitination and Deubiquitination in Apoptotic Protein Stability and Cancer Cell Survival"],"prefix":"10.3390","volume":"27","author":[{"given":"Miso","family":"Choi","sequence":"first","affiliation":[{"name":"Department of Biomedical Science, CHA University, 335 Pangyo-ro, Bundang-gu, Seongnam-si 13488, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7662-7190","authenticated-orcid":false,"given":"Kwang-Hyun","family":"Baek","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science, CHA University, 335 Pangyo-ro, Bundang-gu, Seongnam-si 13488, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.semcancer.2015.03.001","article-title":"Broad targeting of resistance to apoptosis in cancer","volume":"35","author":"Mohammad","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.cell.2026.03.024","article-title":"Cell death in cancer","volume":"189","author":"Conrad","year":"2026","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Gupta, I., Singh, K., Varshney, N.K., and Khan, S. (2018). Delineating crosstalk mechanisms of the ubiquitin proteasome system that regulate apoptosis. Front. Cell Dev. Biol., 6.","DOI":"10.3389\/fcell.2018.00011"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.biochem.78.082307.091526","article-title":"Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes","volume":"78","author":"Ventii","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1042\/BCJ20160082","article-title":"Ubiquitin C-terminal hydrolase L1 (UCH-L1): Structure, distribution and roles in brain function and dysfunction","volume":"473","author":"Bishop","year":"2016","journal-title":"Biochem. J."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Liu, J., Leung, C.T., Liang, L., Wang, Y., Chen, J., Lai, K.P., and Tse, W.K.F. (2022). Deubiquitinases in cancers: Aspects of proliferation, metastasis, and apoptosis. Cancers, 14.","DOI":"10.3390\/cancers14143547"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41568-023-00633-y","article-title":"Deubiquitinases in cancer","volume":"23","author":"Dewson","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Liang, X.W., Wang, S.Z., Liu, B., Chen, J.C., Cao, Z., Chu, F.R., Lin, X., Liu, H., and Wu, J.C. (2023). A review of deubiquitinases and their roles in tumorigenesis and development. Front. Bioeng. Biotechnol., 11.","DOI":"10.3389\/fbioe.2023.1204472"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1038\/s41467-025-57873-9","article-title":"Combinatorial ubiquitin code degrades deubiquitylation-protected substrates","volume":"16","author":"Morita","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature737","article-title":"Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization","volume":"416","author":"Li","year":"2002","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e20222171","DOI":"10.1084\/jem.20222171","article-title":"Dominant negative OTULIN-related autoinflammatory syndrome","volume":"221","author":"Davidson","year":"2024","journal-title":"J. Exp. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10863-013-9508-x","article-title":"Bax induces cytochrome c release by multiple mechanisms in mitochondria from MCF7 cells","volume":"45","author":"Zapata","year":"2013","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/onc.2009.36","article-title":"DISC-mediated activation of caspase-2 in DNA damage-induced apoptosis","volume":"28","author":"Olsson","year":"2009","journal-title":"Oncogene"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"30081","DOI":"10.1074\/jbc.M313420200","article-title":"Lipidic pore formation by the concerted action of proapoptotic BAX and tBID","volume":"279","author":"Terrones","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"11549","DOI":"10.1074\/jbc.274.17.11549","article-title":"An APAF-1\u00b7cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9","volume":"274","author":"Zou","year":"1999","journal-title":"J. Biol. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1101\/gad.949602","article-title":"TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac\/DIABLO","volume":"16","author":"Deng","year":"2002","journal-title":"Genes Dev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"36152","DOI":"10.1074\/jbc.C000533200","article-title":"Molecular determinants of the caspase-promoting activity of Smac\/DIABLO and its role in the death receptor pathway","volume":"275","author":"Srinivasula","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"C45","DOI":"10.1152\/ajpcell.00229.2006","article-title":"Bcl-2 family members and apoptosis, taken to heart","volume":"292","author":"Gustafsson","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Qian, S., Wei, Z., Yang, W., Huang, J., Yang, Y., and Wang, J. (2022). The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.985363"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Luo, J., Lu, Z., Lu, X., Chen, L., Cao, J., Zhang, S., Ling, Y., and Zhou, X. (2013). OTUD5 regulates p53 stability by deubiquitinating p53. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0077682"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.canlet.2014.12.005","article-title":"Deubiquitinase OTUD5 mediates the sequential activation of PDCD5 and p53 in response to genotoxic stress","volume":"357","author":"Park","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1074\/jbc.M805871200","article-title":"Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53","volume":"284","author":"Dayal","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1573406413666171020115539","article-title":"USP7: Target validation and drug discovery for cancer therapy","volume":"14","author":"Zhou","year":"2018","journal-title":"Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature24451","article-title":"Molecular basis of USP7 inhibition by selective small-molecule inhibitors","volume":"550","author":"Turnbull","year":"2017","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/nm.4180","article-title":"HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma","volume":"22","author":"Tavana","year":"2016","journal-title":"Nat. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nature07290","article-title":"The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network","volume":"455","author":"Song","year":"2008","journal-title":"Nature"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"ra80","DOI":"10.1126\/scisignal.2001462","article-title":"DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination","volume":"3","author":"Du","year":"2010","journal-title":"Sci. Signal."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1038\/s41598-020-62076-x","article-title":"Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism","volume":"10","author":"Schauer","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1242\/jcs.200162","article-title":"Parkin promotes proteasomal degradation of misregulated BAX","volume":"130","author":"Cakir","year":"2017","journal-title":"J. Cell Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1073\/pnas.1113248109","article-title":"The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax","volume":"109","author":"Johnson","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Choi, H.S., Lim, E.S., and Baek, K.H. (2022). Deubiquitinating enzyme USP12 regulates the pro-apoptosis protein Bax. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232113107"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Choi, H.S., Kim, S.Y., Kim, S.R., and Baek, K.H. (2026). Ubiquitin-specific protease 49 interacts with Bax to modulate apoptosis. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27094102"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41389-026-00632-2","article-title":"Anti-apoptotic BCL-2 family proteins: From regulatory networks to therapeutic targeting","volume":"15","author":"Wang","year":"2026","journal-title":"Oncogenesis"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1042\/BCJ20210352","article-title":"The C-terminal sequences of Bcl-2 family proteins mediate interactions that regulate cell death","volume":"481","author":"Nguyen","year":"2024","journal-title":"Biochem. J."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Tantawy, S.I., Timofeeva, N., Sarkar, A., and Gandhi, V. (2023). Targeting MCL-1 protein to treat cancer: Opportunities and challenges. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1226289"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.7150\/jca.94546","article-title":"Butein inhibits oral squamous cell carcinoma growth via promoting MCL-1 ubiquitination","volume":"15","author":"Wang","year":"2024","journal-title":"J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1158\/0008-5472.CAN-16-3242","article-title":"Mcl-1 degradation is required for targeted therapeutics to eradicate colon cancer cells","volume":"77","author":"Tong","year":"2017","journal-title":"Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10555-011-9330-z","article-title":"Role of the ubiquitin ligase Fbw7 in cancer progression","volume":"31","author":"Cheng","year":"2012","journal-title":"Cancer Metastasis Rev."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature08646","article-title":"Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival","volume":"463","author":"Schwickart","year":"2010","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41467-017-02693-9","article-title":"Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors","volume":"9","author":"Zhang","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/s41388-021-01679-8","article-title":"The deubiquitinase (DUB) USP13 promotes Mcl-1 stabilisation in cervical cancer","volume":"40","author":"Morgan","year":"2021","journal-title":"Oncogene"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1073\/pnas.1814742116","article-title":"MGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer","volume":"116","author":"Wu","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12935-019-0936-5","article-title":"The deubiquitinating enzyme OTUD1 antagonizes BH3-mimetic inhibitor induced cell death through regulating the stability of the MCL1 protein","volume":"19","author":"Wu","year":"2019","journal-title":"Cancer Cell Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1038\/s41375-025-02694-4","article-title":"Superoxide-mediated phosphorylation and stabilization of Mcl-1 by AKT underlie venetoclax resistance in hematologic malignancies","volume":"39","author":"Chong","year":"2025","journal-title":"Leukemia"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Abbas, R., and Larisch, S. (2021). Killing by degradation: Regulation of apoptosis by the ubiquitin-proteasome-system. Cells, 10.","DOI":"10.3390\/cells10123465"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Ranjan, K., and Pathak, C. (2024). Cellular dynamics of Fas-associated death domain in the regulation of cancer and inflammation. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063228"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1038\/s41467-024-47990-2","article-title":"Deciphering DED assembly mechanisms in FADD-procaspase-8-cFLIP complexes regulating apoptosis","volume":"15","author":"Yang","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/onc.2016.215","article-title":"USP8 suppresses death receptor-mediated apoptosis by enhancing FLIP(L) stability","volume":"36","author":"Jeong","year":"2017","journal-title":"Oncogene"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Farag, M., Kieffer, C., Guedeney, N., Voisin-Chiret, A.S., and Sopkova-de Oliveira Santos, J. (2023). Computational tool to design small synthetic inhibitors selective for XIAP-BIR3 domain. Molecules, 28.","DOI":"10.3390\/molecules28135155"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"851","DOI":"10.15252\/emmm.201506047","article-title":"USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma","volume":"8","author":"Engel","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Cetraro, P., Plaza-Diaz, J., MacKenzie, A., and Abad\u00eda-Molina, F. (2022). A review of the current impact of inhibitors of apoptosis proteins and their repression in cancer. Cancers, 14.","DOI":"10.3390\/cancers14071671"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.molcel.2008.05.014","article-title":"cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination","volume":"30","author":"Bertrand","year":"2008","journal-title":"Mol. Cell"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Sun, Y., Li, S., Mitra, B., Zhong, L., Zhang, A., and Gewurz, B.E. (2026). Epstein-Barr virus latent membrane protein 1 targets cIAP1, cIAP2 and TRAF2 for proteasomal degradation to activate the non-canonical NF-\u03baB pathway. PLoS Pathog., 22.","DOI":"10.1101\/2025.09.06.674652"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jphs.2023.11.002","article-title":"Simultaneous XIAP and cIAP1\/2 inhibition by a dimeric SMAC mimetic AZD5582 induces apoptosis in multiple myeloma","volume":"154","author":"Kikuchi","year":"2024","journal-title":"J. Pharmacol. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"107463","DOI":"10.1016\/j.jbc.2024.107463","article-title":"USP36 inhibits apoptosis by deubiquitinating cIAP1 and survivin in colorectal cancer cells","volume":"300","author":"Gao","year":"2024","journal-title":"J. Biol. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/emboj.2013.62","article-title":"OTUB1 modulates c-IAP1 stability to regulate signalling pathways","volume":"32","author":"Goncharov","year":"2013","journal-title":"Embo J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"35380","DOI":"10.1074\/jbc.M111.282020","article-title":"The USP19 deubiquitinase regulates the stability of c-IAP1 and c-IAP2","volume":"286","author":"Mei","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1158\/1535-7163.MCT-13-0798","article-title":"Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-\u03baB activation, and is active in patient-derived xenograft models","volume":"13","author":"Benetatos","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1200\/JCO.2013.52.3993","article-title":"Phase I dose-escalation study of LCL161, an oral inhibitor of apoptosis proteins inhibitor, in patients with advanced solid tumors","volume":"32","author":"Infante","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","article-title":"Ubiquitination in the regulation of inflammatory cell death and cancer","volume":"28","author":"Cockram","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Du, J., and Wang, Z. (2024). Regulation of RIPK1 phosphorylation: Implications for inflammation, cell death, and therapeutic interventions. Biomedicines, 12.","DOI":"10.20944\/preprints202404.0639.v1"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41419-023-06183-3","article-title":"The mechanism of linear ubiquitination in regulating cell death and correlative diseases","volume":"14","author":"Gao","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/cdd.2017.46","article-title":"CYLD, A20 and OTULIN deubiquitinases in NF-\u03baB signaling and cell death: So similar, yet so different","volume":"24","author":"Lork","year":"2017","journal-title":"Cell Death Differ."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nature02794","article-title":"De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling","volume":"430","author":"Wertz","year":"2004","journal-title":"Nature"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Xiao, H., Han, Z., Xu, M., Gao, X., Qiu, S., Ren, N., Yi, Y., and Zhou, C. (2025). The role of post-translational modifications in necroptosis. Biomolecules, 15.","DOI":"10.3390\/biom15040549"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1021\/jm010468s","article-title":"Inhibition of protein-protein association by small molecules: Approaches and progress","volume":"45","author":"Toogood","year":"2002","journal-title":"J. Med. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrd.2016.29","article-title":"Small molecules, big targets: Drug discovery faces the protein-protein interaction challenge","volume":"15","author":"Scott","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours","volume":"435","author":"Oltersdorf","year":"2005","journal-title":"Nature"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"24882","DOI":"10.1074\/jbc.M111.255828","article-title":"Multiple BH3 mimetics antagonize antiapoptotic MCL1 protein by inducing the endoplasmic reticulum stress response and up-regulating BH3-only protein NOXA","volume":"286","author":"Albershardt","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_70","first-page":"1001","article-title":"The MDM2-p53 interaction","volume":"1","author":"Moll","year":"2003","journal-title":"Mol. Cancer Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/onc.2009.45","article-title":"PUMA, a potent killer with or without p53","volume":"27","author":"Yu","year":"2008","journal-title":"Oncogene"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jb\/mvac041","article-title":"Targeted protein degradation and drug discovery","volume":"172","author":"Naito","year":"2022","journal-title":"J. Biochem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41589-022-00971-2","article-title":"Deubiquitinase-targeting chimeras for targeted protein stabilization","volume":"18","author":"Henning","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nature09297","article-title":"Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1","volume":"466","author":"Nakada","year":"2010","journal-title":"Nature"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.molcel.2012.01.011","article-title":"OTUB1 co-opts Lys48-linked ubiquitin recognition to suppress E2 enzyme function","volume":"45","author":"Juang","year":"2012","journal-title":"Mol. Cell"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1021\/acs.jmedchem.4c02975","article-title":"Deubiquitinase-targeting chimeras (DUBTACs) as a potential paradigm-shifting drug discovery approach","volume":"68","author":"Ma","year":"2025","journal-title":"J. Med. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1158\/0008-5472.CAN-10-1530","article-title":"Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis","volume":"70","author":"Kapuria","year":"2010","journal-title":"Cancer Res."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Zhou, Z., Song, X., Kang, R., and Tang, D. (2022). The emerging role of deubiquitinases in cell death. Biomolecules, 12.","DOI":"10.3390\/biom12121825"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3324\/haematol.2023.283730","article-title":"Ubiquitin-proteasome pathway-mediated regulation of the Bcl-2 family: Effects and therapeutic approaches","volume":"109","author":"Tang","year":"2024","journal-title":"Haematologica"},{"key":"ref_80","first-page":"361","article-title":"Endoplasmic reticulum stress and proteasome inhibitors in multiple myeloma: Room for improvement","volume":"131","author":"Kubicki","year":"2021","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1007\/s10637-020-00915-4","article-title":"Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and\/or refractory multiple myeloma","volume":"38","author":"Rowinsky","year":"2020","journal-title":"Investig. New Drugs"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.molcel.2005.01.008","article-title":"The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway","volume":"17","author":"Nijman","year":"2005","journal-title":"Mol. Cell"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ncb1378","article-title":"Regulation of monoubiquitinated PCNA by DUB autocleavage","volume":"8","author":"Huang","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1158\/0008-5472.CAN-24-0293","article-title":"The USP1 inhibitor KSQ-4279 overcomes PARP inhibitor resistance in homologous recombination-deficient tumors","volume":"84","author":"Cadzow","year":"2024","journal-title":"Cancer Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"12793","DOI":"10.1038\/srep12793","article-title":"HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response","volume":"5","author":"Lim","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"106128","DOI":"10.1016\/j.bioorg.2022.106128","article-title":"Design, synthesis and biological evaluation of 2-aminopyridine derivatives as USP7 inhibitors","volume":"129","author":"Xu","year":"2022","journal-title":"Bioorg. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.bmcl.2017.01.018","article-title":"Synthesis and biological evaluation of thiazole derivatives as novel USP7 inhibitors","volume":"27","author":"Chen","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.chembiol.2011.08.018","article-title":"Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes","volume":"18","author":"Altun","year":"2011","journal-title":"Chem. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nature24006","article-title":"USP7 small-molecule inhibitors interfere with ubiquitin binding","volume":"550","author":"Kategaya","year":"2017","journal-title":"Nature"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ccr.2012.08.007","article-title":"A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance","volume":"22","author":"Chauhan","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.chembiol.2012.02.007","article-title":"Discovery of specific inhibitors of human USP7\/HAUSP deubiquitinating enzyme","volume":"19","author":"Reverdy","year":"2012","journal-title":"Chem. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Kim, S., Woo, S.M., Min, K.J., Seo, S.U., Lee, T.J., Kubatka, P., Kim, D.E., and Kwon, T.K. (2019). WP1130 enhances TRAIL-induced apoptosis through USP9X-dependent miR-708-mediated downregulation of c-FLIP. Cancers, 11.","DOI":"10.3390\/cancers11030344"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1182\/blood-2014-10-605584","article-title":"Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies","volume":"125","author":"Peterson","year":"2015","journal-title":"Blood"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.1038\/ncomms5763","article-title":"Screening of DUB activity and specificity by MALDI-TOF mass spectrometry","volume":"5","author":"Ritorto","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Mofers, A., Perego, P., Selvaraju, K., Gatti, L., Gullbo, J., Linder, S., and D\u2019Arcy, P. (2019). Analysis of determinants for in vitro resistance to the small molecule deubiquitinase inhibitor b-AP15. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0223807"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1038\/s41401-023-01136-0","article-title":"Targeting proteasomal deubiquitinases USP14 and UCHL5 with b-AP15 reduces 5-fluorouracil resistance in colorectal cancer cells","volume":"44","author":"Ding","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e492","DOI":"10.1038\/bcj.2016.93","article-title":"Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells","volume":"6","author":"Paulus","year":"2016","journal-title":"Blood Cancer J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2147\/OTT.S463217","article-title":"Synergistic effect of ubiquitin-specific protease 14 and poly(ADP-ribose) glycohydrolase co-inhibition in BRCA1-mutant, poly(ADP-ribose) polymerase inhibitor-resistant triple-negative breast cancer cells","volume":"17","author":"Li","year":"2024","journal-title":"Oncol. Targets Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/nm.2536","article-title":"Inhibition of proteasome deubiquitinating activity as a new cancer therapy","volume":"17","author":"Brnjic","year":"2011","journal-title":"Nat. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"19209","DOI":"10.1074\/jbc.M117.815126","article-title":"An inhibitor of the proteasomal deubiquitinating enzyme USP14 induces tau elimination in cultured neurons","volume":"292","author":"Boselli","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/cbdd.12571","article-title":"Synthesis and evaluation of derivatives of the proteasome deubiquitinase inhibitor b-AP15","volume":"86","author":"Wang","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1021\/acs.jmedchem.0c00144","article-title":"Re-evaluating the mechanism of action of \u03b1,\u03b2-unsaturated carbonyl DUB inhibitors b-AP15 and VLX1570: A paradigmatic example of unspecific protein cross-linking with michael acceptor motif-containing drugs","volume":"63","author":"Ward","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nchembio.1455","article-title":"A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses","volume":"10","author":"Liang","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10495-022-01736-x","article-title":"ML323, a USP1 inhibitor triggers cell cycle arrest, apoptosis and autophagy in esophageal squamous cell carcinoma cells","volume":"27","author":"Sun","year":"2022","journal-title":"Apoptosis"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Wu, L., Yu, M., Liang, H., Lin, L., Li, H., Chen, G., Muhetaer, H., Li, J., Wu, B., and Jia, X. (2025). SJB2-043, a USP1 inhibitor, suppresses A549 cell proliferation, migration, and EMT via modulation of PI3K\/AKT\/mTOR, MAPK, and Wnt signaling pathways. Curr. Issues Mol. Biol., 47.","DOI":"10.3390\/cimb47030155"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.chembiol.2011.08.014","article-title":"Selective and cell-active inhibitors of the USP1\/UAF1 deubiquitinase complex reverse cisplatin resistance in non-small cell lung cancer cells","volume":"18","author":"Chen","year":"2011","journal-title":"Chem. Biol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2011.08.037","article-title":"Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13","volume":"147","author":"Liu","year":"2011","journal-title":"Cell"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41401-020-0455-x","article-title":"Wu-5, a novel USP10 inhibitor, enhances crenolanib-induced FLT3-ITD-positive AML cell death via inhibiting FLT3 and AMPK pathways","volume":"42","author":"Yu","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1126\/science.1230161","article-title":"A strategy for modulation of enzymes in the ubiquitin system","volume":"339","author":"Ernst","year":"2013","journal-title":"Science"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1016\/j.jmb.2017.05.025","article-title":"Generation and validation of intracellular ubiquitin variant inhibitors for USP7 and USP10","volume":"429","author":"Zhang","year":"2017","journal-title":"J. Mol. Biol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s10495-024-02008-6","article-title":"Deubiquitinating enzyme USP28 inhibitor AZ1 alone and in combination with cisplatin for the treatment of non-small cell lung cancer","volume":"29","author":"Song","year":"2024","journal-title":"Apoptosis"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"115369","DOI":"10.1016\/j.ejmech.2023.115369","article-title":"Structure-based discovery of potent USP28 inhibitors derived from vismodegib","volume":"254","author":"Zhou","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.apsb.2019.12.008","article-title":"Discovery of [1,2,3]triazolo[4,5-d]pyrimidine derivatives as highly potent, selective, and cellularly active USP28 inhibitors","volume":"10","author":"Liu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1021\/acschembio.7b00334","article-title":"Identification and characterization of dual inhibitors of the USP25\/28 deubiquitinating enzyme subfamily","volume":"12","author":"Wrigley","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ncb1601","article-title":"The ubiquitin-specific protease USP28 is required for MYC stability","volume":"9","author":"Popov","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"10140","DOI":"10.1021\/acs.jmedchem.5c03045","article-title":"Structure merging approach leads to new dual potent and selective USP25\/USP28 inhibitors","volume":"69","author":"Patzke","year":"2026","journal-title":"J. Med. Chem."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e71596","DOI":"10.7554\/eLife.71596","article-title":"USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma","volume":"10","author":"Ruiz","year":"2021","journal-title":"Elife"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1038\/s44319-024-00167-w","article-title":"Structural basis for the bi-specificity of USP25 and USP28 inhibitors","volume":"25","author":"Patzke","year":"2024","journal-title":"EMBO Rep."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.chembiol.2017.03.002","article-title":"Lithocholic acid hydroxyamide destabilizes cyclin D1 and induces G(0)\/G(1) arrest by inhibiting deubiquitinase USP2a","volume":"24","author":"Magiera","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e22329","DOI":"10.1096\/fj.202101914RR","article-title":"Ribonucleotide reductase holoenzyme inhibitor COH29 interacts with deubiquitinase ubiquitin-specific protease 2 and downregulates its substrate protein cyclin D1","volume":"36","author":"Zhu","year":"2022","journal-title":"Faseb J."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1038\/s41598-018-21476-w","article-title":"6-Thioguanine is a noncompetitive and slow binding inhibitor of human deubiquitinating protease USP2","volume":"8","author":"Chuang","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"24628","DOI":"10.1074\/jbc.M116.738567","article-title":"Small molecule inhibition of the ubiquitin-specific protease USP2 accelerates cyclin D1 degradation and leads to cell cycle arrest in colorectal cancer and mantle cell lymphoma models","volume":"291","author":"Davis","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/sj.emboj.7601567","article-title":"The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2","volume":"26","author":"Stevenson","year":"2007","journal-title":"Embo J."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12967-024-06001-0","article-title":"A novel USP4 inhibitor that suppresses colorectal cancer stemness by promoting \u03b2-catenin and Twist1 degradation","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"157","DOI":"10.33594\/000000127","article-title":"A selective inhibitor of ubiquitin-specific protease 4 suppresses colorectal cancer progression by regulating \u03b2-catenin signaling","volume":"53","author":"Nguyen","year":"2019","journal-title":"Cell Physiol. Biochem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"118213","DOI":"10.1016\/j.bmc.2025.118213","article-title":"Synthesis of USP5-IN-1 derivatives as novel USP5 inhibitors with potent activity against cholangiocarcinoma cells","volume":"126","author":"Hu","year":"2025","journal-title":"Bioorg. Med. Chem."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"15017","DOI":"10.1021\/acs.jmedchem.1c00889","article-title":"Structure-activity relationship of USP5 inhibitors","volume":"64","author":"Mann","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"8914","DOI":"10.1021\/acs.jmedchem.2c00013","article-title":"Discovery of potent small-molecule USP8 inhibitors for the treatment of breast cancer through regulating ER\u03b1 expression","volume":"65","author":"Tian","year":"2022","journal-title":"J. Med. Chem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1091\/mbc.e05-06-0560","article-title":"Regulation of epidermal growth factor receptor down-regulation by UBPY-mediated deubiquitination at endosomes","volume":"16","author":"Mizuno","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"103962","DOI":"10.1016\/j.bioorg.2020.103962","article-title":"Discovery of novel USP8 inhibitors via Ubiquitin-Rho-110 fluorometric assay based high throughput screening","volume":"101","author":"Han","year":"2020","journal-title":"Bioorg. Chem."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1158\/1541-7786.MCR-12-0699","article-title":"Mitoxantrone targets human ubiquitin-specific peptidase 11 (USP11) and is a potent inhibitor of pancreatic cancer cell survival","volume":"11","author":"Burkhart","year":"2013","journal-title":"Mol. Cancer Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/ncb2874","article-title":"Deubiquitylation and stabilization of PTEN by USP13","volume":"15","author":"Zhang","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1016\/j.apsb.2025.07.003","article-title":"USP20 as a super-enhancer-regulated gene drives T-ALL progression via HIF1A deubiquitination","volume":"15","author":"Xu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/sj.embor.7400377","article-title":"VHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1alpha","volume":"6","author":"Li","year":"2005","journal-title":"EMBO Rep."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1021\/acs.jmedchem.2c01933","article-title":"Discovery and characterization of BAY-805, a potent and selective inhibitor of ubiquitin-specific protease USP21","volume":"66","author":"Vu","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"106842","DOI":"10.1016\/j.bioorg.2023.106842","article-title":"Discovery of selective and potent USP22 inhibitors via structure-based virtual screening and bioassays exerting anti-tumor activity","volume":"141","author":"Zhang","year":"2023","journal-title":"Bioorg. Chem."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"eabo4116","DOI":"10.1126\/sciadv.abo4116","article-title":"A deubiquitination module essential for T(reg) fitness in the tumor microenvironment","volume":"8","author":"Montauti","year":"2022","journal-title":"Sci. Adv."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1038\/s41418-021-00778-z","article-title":"USP24 promotes drug resistance during cancer therapy","volume":"28","author":"Wang","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_139","first-page":"2255","article-title":"NCI677397 targeting USP24-mediated induction of lipid peroxidation induces ferroptosis in drug-resistant cancer cells","volume":"18","author":"Wang","year":"2024","journal-title":"Mol. Oncol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2023.03.263","article-title":"Plumbagin is a novel GPX4 protein degrader that induces apoptosis in hepatocellular carcinoma cells","volume":"203","author":"Yao","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/cr.2014.20","article-title":"A small natural molecule promotes mitochondrial fusion through inhibition of the deubiquitinase USP30","volume":"24","author":"Yue","year":"2014","journal-title":"Cell Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s11658-022-00407-8","article-title":"MF-094 nanodelivery inhibits oral squamous cell carcinoma by targeting USP30","volume":"27","author":"Zhang","year":"2022","journal-title":"Cell Mol. Biol. Lett."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"100609","DOI":"10.1016\/j.mcpro.2023.100609","article-title":"Structural premise of selective deubiquitinase USP30 inhibition by small-molecule benzosulfonamides","volume":"22","author":"Jones","year":"2023","journal-title":"Mol. Cell Proteom."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1016\/j.bmcl.2018.05.013","article-title":"Novel highly selective inhibitors of ubiquitin specific protease 30 (USP30) accelerate mitophagy","volume":"28","author":"Kluge","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/nature13418","article-title":"The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy","volume":"510","author":"Bingol","year":"2014","journal-title":"Nature"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"12020","DOI":"10.1021\/jacs.0c04527","article-title":"Discovery of a potent and selective covalent inhibitor and activity-based probe for the deubiquitylating enzyme UCHL1, with antifibrotic activity","volume":"142","author":"Panyain","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.chembiol.2003.08.010","article-title":"Discovery of inhibitors that elucidate the role of UCH-L1 activity in the H1299 lung cancer cell line","volume":"10","author":"Liu","year":"2003","journal-title":"Chem. Biol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1038\/s41467-022-33559-4","article-title":"Structural basis for specific inhibition of the deubiquitinase UCHL1","volume":"13","author":"Grethe","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1016\/j.bmcl.2007.04.027","article-title":"Structure-activity relationship, kinetic mechanism, and selectivity for a new class of ubiquitin C-terminal hydrolase-L1 (UCH-L1) inhibitors","volume":"17","author":"Mermerian","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41419-019-1628-8","article-title":"A novel UCHL(3) inhibitor, perifosine, enhances PARP inhibitor cytotoxicity through inhibition of homologous recombination-mediated DNA double strand break repair","volume":"10","author":"Song","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1101\/gad.289439.116","article-title":"A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination","volume":"30","author":"Luo","year":"2016","journal-title":"Genes Dev."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/jcp.22931","article-title":"Essential role of ubiquitin C-terminal hydrolases UCHL1 and UCHL3 in mammalian oocyte maturation","volume":"227","author":"Mtango","year":"2012","journal-title":"J. Cell Physiol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nchembio.2326","article-title":"Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11","volume":"13","author":"Li","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1021\/acs.jmedchem.6b01379","article-title":"Discovery of an inhibitor of the proteasome subunit Rpn11","volume":"60","author":"Perez","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.chembiol.2018.07.012","article-title":"Epidithiodiketopiperazines inhibit protein degradation by targeting proteasome deubiquitinase Rpn11","volume":"25","author":"Li","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nchembio.2370","article-title":"Thiolutin is a zinc chelator that inhibits the Rpn11 and other JAMM metalloproteases","volume":"13","author":"Lauinger","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41375-021-01336-9","article-title":"Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2","volume":"36","author":"Yang","year":"2022","journal-title":"Leukemia"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41392-023-01706-y","article-title":"Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (liver kinase B1) activity","volume":"9","author":"Yuan","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/s41418-020-00639-1","article-title":"The deubiquitinase JOSD2 is a positive regulator of glucose metabolism","volume":"28","author":"Krassikova","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"13645","DOI":"10.1021\/acs.jmedchem.2c00408","article-title":"Discovery of potent OTUB1\/USP8 dual inhibitors targeting proteostasis in non-small-cell lung cancer","volume":"65","author":"Tan","year":"2022","journal-title":"J. Med. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/18\/8049\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:16:50Z","timestamp":1789031810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/18\/8049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":160,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27188049"],"URL":"https:\/\/doi.org\/10.3390\/ijms27188049","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}